Drug intelligence / Profile preview

paracetamol + pseudoephedrine hydrochloride + dextromethorphan hydrobromide + chlorpheniramine maleate

Development stage
Phase 4
Lead developer
GSK
Modality
Small Molecules
Administration
Oral
01

Overview

This combination drug contains four active ingredients: **paracetamol (acetaminophen)**, a pain reliever and fever reducer; **pseudoephedrine hydrochloride**, a sympathomimetic decongestant; **dextromethorphan hydrobromide**, a non-opioid cough suppressant; and **chlorpheniramine maleate**, a first-generation antihistamine. It is used to relieve symptoms associated with the common cold and flu, such as headache, fever, body aches, cough, sore throat, nasal congestion, runny nose, sneezing, and sinus pressure. Mechanistically, it targets prostaglandin synthesis (paracetamol), adrenergic receptors in nasal mucosa (pseudoephedrine), the cough center in the medulla (dextromethorphan), and histamine H1 receptors (chlorpheniramine)[1][2][3][5].

Brand names
Theraflu Nighttime Maximum StrengthTheraflu Severe Cold and CongestionTylenol Cold + Flu Multi-Action Day/Night Extra StrengthVicks 44 Cold Flu and CoughVicks44 Cold Flu and CoughVicks-44 Cold Flu and CoughRobitussin FluComtrex Nighttime Cold and CoughTriaminic Flu Cough and FeverTheraflu-DVicks Formula 44MEXTRA STRENGTH TYLENOL COLD PLUS FLU MULTI-ACTION DAY/NIGHT
Other names
acetaminophen + pseudoephedrine hydrochloride + dextromethorphan hydrobromide + chlorpheniramine maleateacetaminophen + chlorpheniramine + dextromethorphan + pseudoephedrine
02

Targets

ADRA1A (α1A)HRH1 (Histamine H1 Receptor)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)SIGMAR1 (Sigma non-opioid intracellular receptor 1)ADRA1 (Alpha-1 adrenergic receptor family)

Beyond the preview

Go deeper on paracetamol + pseudoephedrine hydrochloride + dextromethorphan hydrobromide + chlorpheniramine maleate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on paracetamol + pseudoephedrine hydrochloride + dextromethorphan hydrobromide + chlorpheniramine maleate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call